Contents

Premium Noble Kava
Entdecken Sie zertifizierte Qualität und Reinheit bei unserem offiziellen Partner.
Zu Kava-mode.comBrief & Concise
The anxiolytic effect (anxiolysis) is the best-documented and scientifically studied property of Kava. For millennia, the peoples of the Pacific have used the plant to find inner peace – and modern research confirms this traditional use.
In contrast to pharmaceutical anxiolytics like benzodiazepines, Kava works without cognitive impairments. The mind remains clear and focused while tension and worries dissolve. This unique state is often described as "alert relaxation" or "active calmness."
Mechanism of Action
The anxiolytic effect of Kava is based on a complex interplay of several neurobiological mechanisms. At the center is the modulation of the GABA system, but other neurotransmitter systems are also involved.
The GABA System
GABA (Gamma-Aminobutyric acid) is the most important inhibitory neurotransmitter in the brain. When GABA binds to its receptor, a chloride channel opens, negative ions flow into the nerve cell, and it becomes less excitable. The result: Calmness, relaxation, anxiety relief.
The Process of GABA Modulation
- 1. Kavalactone (e.g., Kavain) reaches the brain via the bloodstream
- 2. Binding to the GABA-A receptor on nerve cells (at a different site than benzodiazepines)
- 3. Opening of the chloride channel → increased influx of Cl⁻ ions
- 4. Neuronal hyperpolarization → the excitability of the neuron decreases
- 5. Noticeable effect: Calmness, anxiety relief, muscular relaxation
The crucial difference from benzodiazepines: Kavalactones bind at a different site on the GABA-A receptor. This explains why Kava does not cause dependence and does not impair cognitive functions.
Additional Mechanisms
Sodium/Calcium Channel Blockade
Kavalactones block voltage-dependent sodium and calcium channels. This reduces the excitability of nerve cells and contributes to the calming effect. This mechanism is also responsible for the anticonvulsive effect.
MAO-B Inhibition
Some Kavalactones (especially Desmethoxyyangonin) inhibit the enzyme monoamine oxidase-B. This slows down the breakdown of dopamine and contributes to the mood-enhancing effect – without the risks of classical MAO inhibitors.
Norepinephrine Reuptake Inhibition
The inhibition of norepinephrine reuptake contributes to enhanced concentration without causing nervousness. This explains the "alert relaxation" that distinguishes Kava from sedative substances.
CB1 Receptor Affinity
Yangonin shows a proven affinity for the CB1 receptor of the endocannabinoid system. This explains the slightly euphoric component of Kava's effect.
Scientific Studies
The anxiolytic effect of Kava is supported by numerous clinical studies. A Cochrane meta-analysis from 2003 (updated in 2018) summarized the results and reached a positive conclusion.
Key Study Results
- Cochrane Review (Pittler & Ernst, 2003): Analysis of 11 randomized controlled trials with a total of 645 participants. Kava showed a significant superiority over placebo in the treatment of anxiety disorders.
- Sarris et al. (2013): Double-blind, placebo-controlled study with 75 participants with generalized anxiety disorder. Kava extract (120-240 mg Kavalactones/day) led to a significant reduction in anxiety symptoms.
- Lehrl (2004): Comparative study between Kava and Oxazepam (benzodiazepine). Both showed comparable anxiolytic effects, but Kava without cognitive impairment.
"The evidence for Kava is particularly strong in the area of anxiety relief. Studies show a reduction in physiological stress markers (e.g., heart rate, cortisol) after taking Kava extracts or traditional beverages."
Kava vs. Benzodiazepines
The comparison between Kava and benzodiazepines is particularly enlightening, as both act on the GABA system but with very different outcomes.
| Property | Kava | Benzodiazepines |
|---|---|---|
| Anxiolytic Effect | Strong, but gentle | Very strong |
| Cognitive Function | Maintained or improved | Impaired |
| Sedation | Low to moderate | Strong |
| Dependence Potential | Very low | High (after a few weeks) |
| Tolerance Development | Reverse Tolerance | Rapid Tolerance |
| Withdrawal Symptoms | None known | Severe, potentially dangerous |
| Interactions | Low | Numerous |
Advantages of Kava
- No development of dependence even with prolonged use
- Mental clarity remains intact – ideal for work and social situations
- No "hangover" or rebound anxiety the next day
- Can be taken as needed without developing tolerance
- Natural product with millennia-old tradition
Recommended Chemotypes & Varieties
For the anxiolytic effect, varieties with a high Kavain content (position 4 in the chemotype) are particularly recommended. These "Heady" Kavas primarily act mentally and keep the mind clear.
Borogu (Vanuatu)
Chemotyp: 426531
Classic Noble Kava, balanced with a slight Heady tendency. Ideal for beginners.
Kelai (Vanuatu)
Chemotyp: 423165
Strongly anxiolytic, very popular. Clear, focused relaxation.
Melo Melo (Vanuatu)
Chemotyp: 463251
Heady with slight euphoria. Ideal for social situations.
Pouni Ono (Tonga)
Chemotyp: 426315
Mood-enhancing and anxiety-relieving. Premium quality.
Not Recommended for Anxiety Relief
Tudei Varieties (identified by DHM in position 1 or 2, e.g., chemotype 526431) are not suitable for anxiety treatment. They have strong sedative effects and can lead to fatigue the next day. Also, very "Heavy" varieties can be counterproductive when clarity is desired.
Practical Application
For the application in anxiety disorders, there are various strategies depending on whether it concerns acute situations or long-term support.
In Acute Anxiety
- Dosage: 1-2 Shells (approx. 15-30g powder)
- Preparation: Traditionally kneaded in water
- Onset of Effect: 15-30 minutes
- Variety: Heady Kava (e.g., Kelai, Borogu)
- Tip: On an empty stomach for faster effect
For Daily Support
- Dosage: 100-250 mg Kavalactones/day
- Form: Traditional drink or capsules
- Timing: Evening or as needed
- Note: "Reverse Tolerance" – effect may increase over time
- Break: 1-2 days per week recommended
Reverse Tolerance
A unique phenomenon with Kava: Unlike most psychoactive substances, the effect can become stronger with regular use, not weaker. Beginners often require higher doses, while experienced users can manage with less. This makes Kava a sustainable option for long-term anxiety management.
Continue in the chapter Effect:
Sleep & Relaxation
How Kava improves sleep and promotes deep relaxation
With contributions from
This wiki is a curated resource that synthesizes research from peer-reviewed studies and expert researchers. It is not written by the researchers listed above, but rather based on their published work.
Scientific Sources
The information on this page is based on the following scientific studies and publications:
Kava extract for treating anxiety (Cochrane Review)
Pittler M.H., Ernst E. (2003) – Cochrane Database of Systematic Reviews
View studyKava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study
Sarris J., Stough C., Bousman C.A., Wahid Z.T., Murray G., Teschke R., Savage K.M., Stough C., Byrne G.J., Scholey A. (2013) – Journal of Affective Disorders
View studyKava-Kava Extract LI 150 Is as Effective as Opipramol and Buspirone in Generalised Anxiety Disorder
Lehrl S. (2004) – Phytomedicine
View studyTherapeutic Potential of Kava in the Treatment of Anxiety Disorders
Singh Y.N., Singh N.N. (2002) – CNS Drugs
View study

